Designing and Validating Effective Search Formulas for Literature Monitoring



Designing and Validating Effective Search Formulas for Literature Monitoring


There is no room for error when it comes to pharmacovigilance.

The FDA and EMA expect 100% of adverse drug reactions to be found in the literature monitoring process, so your search formula must be designed to achieve perfect recall. At the same time, though, you want to minimize the number of irrelevant records retrieved in order to maintain efficiency. The trick is finding that balance between recall and precision.

In this white paper, you will learn about:

  • Creating or revising a search formula so that it achieves 100% recall of ADRs
  • What you can do to improve precision in your searches
  • Searching both with and without existing historical data

Read the white paper.

To access the complimentary white paper 'Designing and Validating Effective Search Formulas for Literature Monitoring', please fill in the form below.

By submitting this form you also agree to receive information relevant to your interests from Elsevier B.V. and its affiliates worldwide. You can opt-out at any time by following the instructions given in the email messages you receive.


Elsevier's R&D Solution supporting 'Precision Medicine, not Limited Medicine: Sustainable Drug Development Builds on Effective Data Use'

QUOSA PV

Promote efficiency and organizational compliance by centralizing the discovery of adverse event information and automating information monitoring and triage in a scalable environment.

Learn more about QUOSA PV
Contact a QUOSA PV expert